Batu Biologics

Here is a paper we published describing scientific mechanisms of Vallovax http://www.oncotarget.com/index.php

FINALLY!!! Chipsa Hospital is bringing legitimacy to Alternative Medicine! They brought together 20+ long term Stage 4 Cancer Survivors and some of the BEST ...Scientists and Doctors in the fields of cancer research, tumor immunology and immunotherapy. This has never been done before! Seems like Alternative Treatments, are no longer "quack" Read about it here: https://alternativehealthscience.com/chipsa-scientific-for/

Here is a paper we published describing scientific mechanisms of Vallovax http://www.oncotarget.com/index.php

Overcoming the systemic toxicity of interleukin-2 therapy by antibody targeting of the cytokineto the tumor micro environment https://www.frontiersin.org/articles//fimmu.2018.02905/full

You are welcomed to watch the fourth video in the Starve The Tumor Immunotherapy Blog series where we discuss some of the historical anti-angiogenesis therapies that have been approved by the FDA and considerations in the design of new angiogenesis inhibitors. For more information, please visit us at: www.batubiologics.com

Interesting piece of history about Batu Biologics CSO, Dr. Thomas Ichim. Its great to see his work in science continue with Batu Biologics' lead immunotherapy, ValloVax!

FINALLY!!! Chipsa Hospital is bringing legitimacy to Alternative Medicine! They brought together 20+ long term Stage 4 Cancer Survivors and some of the BEST ...Scientists and Doctors in the fields of cancer research, tumor immunology and immunotherapy. This has never been done before! Seems like Alternative Treatments, are no longer "quack" Read about it here: https://alternativehealthscience.com/chipsa-scientific-for/

A cool video presentation from two years ago at our previous incubator facility JLABS @ San Diego. Its amazing to see how far we have come since then!

Batu Biologics is enthusiastic to announce the recruitment of Dr. Vijay Mahant to the management team as Vice President of Precision Oncology

In the third episode of the Starve the Tumor Immunotherapy Blog, Batu Biologics CEO, Samuel C. Wagner, discusses some of the historical research in the field of angiogenesis and how this has laid the groundwork for the development of new cancer treatments today.

Samuel C. Wagner shares more information about Batu Biologics in an interview with Tom Schenck of the Villain Crusher Show

Learn more about the unique parallels between the placenta and cancer. Here is The Starve The Tumor Blog, Episode 2 article: https://batubiologics.com//Starve-The-Tumoe-Episode-2-The-

Batu Biologics launches the second Episode of the Starve the Tumor Immunotherapy Blog Series diving in deeper into the similarities between the placenta and cancer.

Take a look at some of our videos to learn more about our research! We cover a range of topics from placenta based research, vaccine adjuvants, and spontaneous remissions. Each episode is backed up with a fully referenced article should anyone be interested in doing their own digging.

Batu Biologics is proud to announce the release of the first article of the Starve The Tumor Immunotherapy Blog Series. Each video will be paired with an informational article to provide interested patients, scientists, and researchers with additional resources to learn more about our technology. Link: https://batubiologics.com//Starve-The-Tumor-Episode-1-How-

We are proud to announce the release of the first episode of the Batu Biologics Starve The Tumor Immunotherapy Blog. In this episode we explore a history of placental based research and discuss how this set the stage today for the discovery of Batu Biologics' novel immunotherapy, ValloVax.